- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00982241
Overactive Bladder (OAB) Drink Advice Study
July 23, 2012 updated by: Radboud University Medical Center
Prospective Intervention Study of Drink Advice in Overactive Bladder Syndrome (OAB)
The researchers want to investigate how fluid intake influences the symptoms of OAB.
The researchers will recruit 45 patients with OAB and randomize them (blind) in 3 groups (low/normal/high fluid intake).
Patients will follow this drink pattern for 2-5 days, while filling in an standard micturation diary for 2 days.
This micturation diary is coupled to: collection of multiple urine samples, urine pH measurements, and a Perception of Intensity of Urgency Scale (PPIUS) scoring table.
All this is collected by the patients themselves.
Urine samples will be analysed for osmolality by the clinical chemistry department.
Study Overview
Status
Withdrawn
Conditions
Intervention / Treatment
Study Type
Interventional
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Gelderland
-
Nijmegen, Gelderland, Netherlands, 6500 HB
- Dept. of Urology, Radboud University Nijmegen Medical Centre
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 75 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- OAB patients
Exclusion Criteria:
- benign prostatic hyperplasia
- neurogenic detrusor overactivity
- urine tract infection
- anticholinergics
- intravesical botulin toxin
- cardiac failure
- renal insufficiency
- sacral neurostimulation
- percutaneous neurostimulation
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: normal fluid intake
1500 ml /day (+/- 300 ml) for 2,5 days
|
drinking water / normal dietary fluids for oral intake
|
Active Comparator: high fluid intake
2400 ml/day (+/- 300 ml )for 2,5 days
|
drinking water / normal dietary fluids for oral intake
|
Active Comparator: low fluid intake
fluid intake 900 ml/day (+/- 300ml) for 2,5 days
|
drinking water / normal dietary fluids for oral intake
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
urine osmolality
Time Frame: 2 days
|
2 days
|
PPIUS urge-score
Time Frame: 2 days
|
2 days
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
urine pH
Time Frame: 2 days
|
2 days
|
PPIUS urge score
Time Frame: 2 days
|
2 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Study Chair: John Heesakkers, dr. MD, dept of Urology, Radboud University Nijmegen Medical Centre
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
July 1, 2009
Primary Completion (Actual)
December 1, 2010
Study Registration Dates
First Submitted
September 22, 2009
First Submitted That Met QC Criteria
September 22, 2009
First Posted (Estimate)
September 23, 2009
Study Record Updates
Last Update Posted (Estimate)
July 24, 2012
Last Update Submitted That Met QC Criteria
July 23, 2012
Last Verified
September 1, 2009
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- OABdrinkstudy
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Overactive Bladder Syndrome
-
Ankara Yildirim Beyazıt UniversityCompletedOveractive Bladder | Overactive Detrusor | Overactive Bladder SyndromeTurkey
-
Taipei Veterans General Hospital, TaiwanRecruitingOveractive Bladder SyndromeTaiwan
-
Buddhist Tzu Chi General HospitalUnknownOveractive Bladder SyndromeTaiwan
-
PfizerCompleted
-
PfizerCompletedOveractive Bladder SyndromeGermany
-
Walter Reed National Military Medical CenterRecruitingOveractive Bladder SyndromeUnited States
-
University Hospital, GhentAstellas Pharma Inc; MedtronicCompleted
-
University Hospital, GhentTerminatedOveractive Bladder SyndromeBelgium
-
Chung Shan Medical UniversityUnknownOveractive Bladder SyndromeTaiwan
-
Far Eastern Memorial HospitalCompletedOveractive Bladder SyndromeTaiwan
Clinical Trials on water
-
Essentia Water, LLCHealth Onvector Inc.Completed
-
University of ManitobaCompleted
-
University Hospital, MontpellierCompletedHealthy | Heat ExposureFrance
-
University of FloridaWithdrawnWeight Loss | Appetitive Behavior | Energy Intake | Water
-
Imam Abdulrahman Bin Faisal UniversityThe Saline Water Conversion Corporation Research Institute at Al-Jubail,...CompletedDiabetes Mellitus | Glucose, High Blood | PatientsSaudi Arabia
-
University of North Carolina, Chapel HillCompleted
-
Singapore General HospitalUnknown
-
University of Novi Sad, Faculty of Sport and Physical...Dom Zdravlja NisCompleted
-
Institute of Progressive MedicineActive, not recruiting
-
Simon Fraser UniversityRecruitingSyncope | Orthostatic Hypotension | Vasovagal SyncopeCanada